DCLX069

CAS No. 792946-69-1

DCLX069( DCLX-069 | DCLX 069 )

Catalog No. M27868 CAS No. 792946-69-1

DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 65 Get Quote
10MG 102 Get Quote
25MG 176 Get Quote
50MG 290 Get Quote
100MG 462 Get Quote
500MG 981 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DCLX069
  • Note
    Research use only, not for human use.
  • Brief Description
    DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.
  • Description
    DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer, and acute myeloid leukemia cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DCLX-069 | DCLX 069
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    DNA alkylator
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    792946-69-1
  • Formula Weight
    339.44
  • Molecular Formula
    C20H25N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (294.61 mM)
  • SMILES
    O=C(OCC)C1=CC=C(N2CCN(CC3=CC=CC=C3)CC2)C(N)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.D T Beranek. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res. 1990 Jul;231(1):11-30.
molnova catalog
related products
  • SD49-7

    SD49-7 is an inhibitor of histone lysine demethylase 4 (KDM4) with an IC50 of 0.19 μM.

  • PFI-90

    PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.

  • M?89

    M-89 inhibits the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction and has potential to treat MLL leukemia.?M-89 is a highly potent and specific menin inhibitor, with a Kd of 1.4 nM for binding to menin.